Arcus Therapeutics Announces Grant of Patent For Vascular Targeting Agent Technology
... chemotherapeutic agents and coagulation proteins to specific tumor blood vessel markers, known as aminophospholipids.......Vascular Targeting represents a new technology for the treatment of solid tumors....... is currently in a multi-center Phase II clinical study for the treatment of brain cancer and in four Phase I clinical studies for the treatment of colorectal,...
Nov 12 8:07 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/011112/122123_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines